Switzerland
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 15.69 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
2 |
USD -22.35 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
3 |
USD -43.06 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
4 |
USD -71.04 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
5 |
USD -72.70 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
6 |
USD -121.90 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
7 |
USD -242.64 M
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
The Vaccines company in Switzerland with the highest Free Cash Flow is Basilea Pharmaceutica AG (Swiss Stock Exchange: BSLN.SW) at USD 15.69 M.
The Vaccines company in Switzerland with the lowest Free Cash Flow is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD -242.64 M.
The top 10 Vaccines companies in Switzerland by Free Cash Flow are Basilea Pharmaceutica AG, PolyPeptide Group AG, MoonLake Immunotherapeutics, Molecular Partners AG, AC Immune SA, ADC Therapeutics SA and Sandoz Group AG.
The bottom 10 Vaccines companies in Switzerland by Free Cash Flow are Sandoz Group AG, ADC Therapeutics SA, AC Immune SA, Molecular Partners AG, MoonLake Immunotherapeutics, PolyPeptide Group AG and Basilea Pharmaceutica AG.